VEGFA and Sensory neuropathy: An increase in sensory neuropathies has been reported in cancer patients receiving VEGF-A antagonists in combination with chemotherapy,36, 37 which is not attributed solely to chemotherapeutics.38 Nociceptors, like RGCs have long axons, and require efficient movement of proteins and organelles to function.